{"disease":{"id":"pregnancy-malaria","name":"pregnancy malaria"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05306067","title":"Plasmodium Falciparum Genomic Intelligence in Mozambique","phase":"","overall_status":"COMPLETED","enrollment_count":21848,"lead_sponsor_name":"Centro de Investigacao em Saude de Manhica","has_results":false},{"nct_id":"NCT04189744","title":"The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":5436,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT03208179","title":"Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4680,"lead_sponsor_name":"Liverpool School of Tropical Medicine","has_results":false},{"nct_id":"NCT05934318","title":"L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)","phase":"NA","overall_status":"RECRUITING","enrollment_count":2960,"lead_sponsor_name":"Liverpool School of Tropical Medicine","has_results":false},{"nct_id":"NCT03754322","title":"LAMP Detection of Malaria in PREGnancy (LAMPREG) Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":2424,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT04158713","title":"Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":898,"lead_sponsor_name":"Liverpool School of Tropical Medicine","has_results":false},{"nct_id":"NCT03172221","title":"Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women","phase":"","overall_status":"COMPLETED","enrollment_count":880,"lead_sponsor_name":"Foundation for Innovative New Diagnostics, Switzerland","has_results":false},{"nct_id":"NCT03431168","title":"A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":308,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT04634695","title":"Assessing to What Extent Dhps-431V Mutation May Influence the Protective Efficacy of IPTp-SP","phase":"","overall_status":"UNKNOWN","enrollment_count":288,"lead_sponsor_name":"Obafemi Awolowo University","has_results":false},{"nct_id":"NCT05285735","title":"Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants","phase":"","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Amivas Inc.","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}